We are live on
!
Find out more
CIM
Contravisory Investment Management Portfolio holdings
AUM
$566M
1-Year Est. Return
42.93%
This Fund
S&P 500
This Quarter
Est. Return
+13.37%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$322M
AUM Growth
+$28.8M
(+9.8%)
Cap. Flow
-$2.72M
Cap. Flow
% of AUM
-0.84%
Top 10 Holdings %
Top 10 Hldgs %
28.37%
Holding
285
New
38
Increased
61
Reduced
112
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Autodesk
ADSK
|
+$5.66M |
| 2 |
Cognex
CGNX
|
+$5.61M |
| 3 |
Trex
TREX
|
+$5.37M |
| 4 |
Union Pacific
UNP
|
+$5.15M |
| 5 |
Rockwell Automation
ROK
|
+$5.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$6.39M |
| 2 |
Kimberly-Clark
KMB
|
+$6.15M |
| 3 |
Lockheed Martin
LMT
|
+$5.33M |
| 4 |
Fidelity National Information Services
FIS
|
+$5M |
| 5 |
Mondelez International
MDLZ
|
+$4.91M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.48% |
| 2 | Healthcare | 17.99% |
| 3 | Financials | 12.48% |
| 4 | Industrials | 10.79% |
| 5 | Communication Services | 8.59% |
Similar funds
SAM
KJWM
PAM
PEP
OC
LC
BRIM
KBG
Contravisory Investment Management's Q4 2020 Portfolio in Review
As of Q4 2020, Contravisory Investment Management held 285 positions worth $322M, up 9.8% from $293M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Contravisory Investment Management's Q4 2020 filing shows 38 new, 61 increased, 112 reduced and 38 closed positions. Its largest new stake was Cognex: 77,192 shares worth $6.2M. The largest sale was AbbVie, an estimated $6.39M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Contravisory Investment Management's largest Q4 2020 buy was Cognex: 77,192 shares worth $6.2M.
- Contravisory Investment Management added most to Autodesk in Q4 2020, an estimated $5.66M increase.
- Contravisory Investment Management's biggest Q4 2020 reduction was AbbVie, cutting an estimated $6.39M.
- Contravisory Investment Management fully exited Kimberly-Clark in Q4 2020, selling an estimated $6.15M.
- Contravisory Investment Management's ten largest holdings make up 28% of its $322M portfolio in Q4 2020.
- Contravisory Investment Management opened 38 new positions and closed 38 in Q4 2020.
- Contravisory Investment Management's portfolio value rose 9.8% quarter-over-quarter to $322M.
Based on Contravisory Investment Management's 13F filing for Q4 2020, filed 13 Jan 2021.